July 14, 2023
David Farber discusses the FDA recently granting full approval to Leqembi, a drug to treat mild Alzheimer’s disease
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
December 12, 2022
David Farber, Preeya Pinto, John Shakow, Eva Temkin and Christine Carletta’s client alert is referenced in a profile on the Inflation Reduction Act of 2022
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
November 18, 2021
David Farber comments on the new infrastructure law and the provisions that are included to improve public health
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
April 9, 2021
David Farber explains why a vaccinated person is not required to share that information with everyone who asks
March 12, 2021
David Farber explains how international reference pricing would impact older adults and their access to prescription drugs
December 31, 2020
King & Spalding Advises on Landmark Medicare Reform Bills BENES Act and PAID Act, Both Passed By Congress
December 16, 2020
David Farber and Christine Carletta file an amicus brief on behalf of Alliance for Aging Research seeking to halt implementation of CMS’ MFN Rule